Wuelfrath, Germany

Claudia Trautwein

USPTO Granted Patents = 27 


 

Average Co-Inventor Count = 6.0

ph-index = 15

Forward Citations = 854(Granted Patents)


Location History:

  • Wuelfrath, DE (2011 - 2023)
  • Tuebingen, DE (2024)

Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
Loading Chart...
27 patents (USPTO):Explore Patents

Title: Innovating Immunotherapy: The Contributions of Claudia Trautwein

Introduction: Claudia Trautwein, based in Wuelfrath, Germany, is a prominent inventor in the field of immunotherapy with an impressive portfolio of 27 patents. Her work primarily focuses on innovative methods to combat various tumors, including neuronal and brain cancers, showcasing her significant contributions to cancer research and therapeutic development.

Latest Patents: Claudia's latest patents center on immunotherapy against several tumors, particularly those affecting the nervous system and the brain. Her inventions encompass peptides, nucleic acids, and cells designed for use in immunotherapeutic methods. Specifically, she has developed 30 peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells. These peptides are crucial as they serve as active pharmaceutical ingredients in vaccine compositions, aiming to elicit anti-tumor immune responses. The potential of her innovations lies in the stimulation of cytotoxic T cell (CTL) responses to enhance cancer treatment effectiveness.

Career Highlights: Trautwein has made substantial advancements in immunotherapy through her role at Immatics Biotechnologies GmbH. Her extensive innovations have positioned her as a key player in the biotechnology industry, where her research efforts are focused on pioneering solutions for complex medical challenges such as cancer.

Collaborations: Throughout her career, Claudia has collaborated with talented professionals, including her coworkers Harpreet Singh and Toni Weinschenk. These partnerships have fostered a collaborative environment crucial for driving innovation in the field of biomedicine, enabling breakthroughs in therapeutic applications.

Conclusion: Claudia Trautwein's dedication to advancing immunotherapy has led to significant innovations that have the potential to revolutionize cancer treatment. Her ongoing efforts in research and collaboration highlight her commitment to improving patient outcomes and contribute to the scientific community’s understanding of cancer immunotherapy. With her remarkable portfolio of patents, she remains a prominent figure in the biotechnology sector, exemplifying the vital role inventors play in shaping the future of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…